1. Home
  2. R vs ABVX Comparison

R vs ABVX Comparison

Compare R & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ryder System Inc.

R

Ryder System Inc.

HOLD

Current Price

$264.74

Market Cap

6.5B

ML Signal

HOLD

Logo Abivax SA American

ABVX

Abivax SA American

HOLD

Current Price

$99.10

Market Cap

7.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
R
ABVX
Founded
1933
2013
Country
United States
France
Employees
N/A
69
Industry
Rental/Leasing Companies
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
7.2B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
R
ABVX
Price
$264.74
$99.10
Analyst Decision
Buy
Buy
Analyst Count
10
13
Target Price
$238.56
$131.31
AVG Volume (30 Days)
334.0K
2.4M
Earning Date
04-23-2026
03-23-2026
Dividend Yield
1.48%
N/A
EPS Growth
7.96
N/A
EPS
2.33
N/A
Revenue
$12,665,000,000.00
N/A
Revenue This Year
$5.00
$52.14
Revenue Next Year
$5.05
$4,132.27
P/E Ratio
$113.08
N/A
Revenue Growth
0.23
N/A
52 Week Low
$157.77
$7.41
52 Week High
$284.25
$148.83

Technical Indicators

Market Signals
Indicator
R
ABVX
Relative Strength Index (RSI) 54.86 43.82
Support Level $183.12 $87.60
Resistance Level N/A $131.50
Average True Range (ATR) 7.45 7.75
MACD -0.82 -0.43
Stochastic Oscillator 42.87 46.23

Price Performance

Historical Comparison
R
ABVX

About R Ryder System Inc.

Ryder System Inc operates in three business segments: (1) Fleet Management Solutions which provides full-service leasing and leasing with flexible maintenance options, commercial rental and maintenance services of trucks, tractors and trailers to customers; (2) Supply Chain Solutions (SCS), which provides integrated logistics solutions, including distribution management, dedicated transportation, transportation management, brokerage, e-commerce, last mile, and professional services; and (3) Dedicated Transportation Solutions (DTS), which provides turnkey transportation solutions in the U.S., including dedicated vehicles, professional drivers, management, and administrative support.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD. The Group operates in a single operating segment: R&D of pharmaceutical products in order to market them in the future.

Share on Social Networks: